/Investor DB

Angels Santé

Angel network

Paris · Pre-Seed–Seed · 14 people tracked

Find your way into Angels Santé

Sign up to see every warm intro you have to Angels Santé

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Angels Santé team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Angels Santé presents itself as the first business angel network in Europe dedicated to health. Its mission is to identify, understand and analyze emerging and promising health projects, favoring the integration of innovative solutions beneficial to patients. The network supports Biotech, Medtech and E-Health startups by drawing on its community of investors and healthcare entrepreneurs, who bring scientific, regulatory and clinical expertise to evaluate each project. It offers members exclusive, qualified dealflow within a supportive and active community, inviting executives, entrepreneurs and healthcare professionals to share resources with young innovative companies.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Seed
HQ
Paris, FR
Instruments
Equity
Tracked investments
16

Team · 14 people

from public directories
Guy-Charles Fanneau de la Horie· Founding Member & Administrator
Pierre-Emmanuel Aubert· Founding Member & Administrator
Eric Garnier· Président
Eric Poulet· Investor
Stephane Mendras· Investor

What they invest in

from 7 of 16 portfolio companies

Medical Devices ×6Biotech ×5Healthtech ×4AI & Machine Learning ×3Deep Tech ×2Digital Health ×2

HQs:France×5

Investments · 16 tracked

founders shown can be your intro path
Open Stent Solutionopenstentsolution.comin✓ verified

Open Stent Solution develops a percutaneous medical device for mitral and tricuspid valve replacement in cardiac patients ineligible for open-heart surgery.

BiotechDeep TechHealthtechMedical DevicesUnknown from page, FR

Co-investorsCapital Cell

Austral Dxaustraldx.frin

AUSTRAL Dx develops AI-powered ultrasound technology for the medtech industry, combining expertise in artificial intelligence and ultrasound imaging with capabilities in product development, regulatory approval, and market commercialization.

AI & Machine LearningDigital HealthMedical DevicesUnknown from this page, FR

Philippe Mendels-Flandre(Co-founder & CEO)inMathieu Couade(Co-founder & CSO)inFrédéric Giral(Co-founder & CTO)in

Co-investorsKima Ventures

Hephaistos-Pharmahephaistos-pharma.frinMay 2024

HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors.

BiotechMedical DevicesOrsay, FR

Martine Caroff(Scientific Founder)inFrederic Caroff(CEO)inFrederique Brune(CDO)inStephan Braun(CMO)inJerome Kerzerho(CSO)inChristel Lonneux(CFO and HR)in

Co-investorsxista science venturesElaiaFemmes Business Angels

Kimialyskimialys.comin

Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsOctalfaSuper Capital VCTurenne Capital Partenaires

Sirius Neosightsirius-neosight.comin

Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples.

BiotechHealthtechMedical DevicesLyon, FR

Arnaud Vigneron(Co-founder)inDavid Gueyrard(Co-founder)inJean-Guillaume Lafay(Co-founder)Stéphane Legastelois(Co-founder)in

Co-investorsOctalfaGO Capital

StemInovsteminov.comin

StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis.

BiotechHealthtechMedical Devices

Julie Hutin(CEO & Co-founder)Danièle Bensoussan(CSO & Co-founder)

Co-investorsBusiness Angels des Grandes Ecoles

Vulgaroovulgaroo.comin

Vulgaroo develops AI-powered solutions to improve medical understanding and diagnosis.

AI & Machine LearningDigital HealthHealthtech

Christophe Lelongin

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AbcelyAlga TherapeuticsByome LabsHOCOIAHuntX PharmaMB TherapeuticsMy HospitelMyfit SolutionWinnove

Frequently asked questions

How many investments has Angels Santé made?
Angels Santé has 16 tracked investments.
What stage does Angels Santé invest at?
Angels Santé invests at the Pre-Seed, Seed stages.
What sectors does Angels Santé focus on?
Angels Santé focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Angels Santé located?
Angels Santé is headquartered in Paris, FR.
Who does Angels Santé co-invest with?
Angels Santé most often shares deals with Octalfa, Femmes Business Angels, Kima Ventures, among 6 tracked co-investors.

Images

Angels Santé photoAngels Santé photo

Similar investors

Featured in lists